Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Boehringer_Ingelheim
|
| gptkbp:acquisitionYear |
2017
|
| gptkbp:country |
gptkb:France
|
| gptkbp:focus |
vaccines
veterinary pharmaceuticals |
| gptkbp:founded |
1997
|
| gptkbp:headquartersLocation |
gptkb:Lyon,_France
|
| gptkbp:industry |
animal health
|
| gptkbp:market |
global
|
| gptkbp:numberOfEmployees |
~6,900
|
| gptkbp:parentCompany |
gptkb:Boehringer_Ingelheim
gptkb:Sanofi |
| gptkbp:product |
gptkb:Frontline
gptkb:Heartgard Ivomec Purevax |
| gptkbp:type |
gptkb:subsidiary
|
| gptkbp:website |
www.merial.com
|
| gptkbp:bfsParent |
gptkb:Boehringer_Ingelheim_Animal_Health
gptkb:Melarsomine |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Merial
|